NCT07476703 Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
| NCT ID | NCT07476703 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Danderyd Hospital |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,400 participants |
| Start Date | 2024-04-08 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,400 participants in total. It began in 2024-04-08 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a unique, large-scale national research initiative involving 30,000 randomly selected individuals aged 50-64, recruited between 2014 and 2018. The study is a collaborative effort among six university hospitals across Sweden. A follow-up study, SCAPIS 2, is conducted for half of the original participants. In Stockholm, 2,500 individuals will be re-examined at Danderyd University Hospital and Karolinska Institutet. SCAPIS 2 includes a core set of examinations involving blood sampling, questionnaires, and imaging. In addition to these, complementary local investigations are conducted to enable more detailed research questions. This protocol describes the additional studies conducted in the Stockholm cohort. All complementary assessments aim to identify risk factors for current and future lung, liver, and cardiovascular diseases.: EXTENDED SAMPLING: Saliva and Blood Samples with Blood Cell Isolation. EXTENDED QUESTIONNAIRES: Dyspnea, Sleep, Respiratory Infections, and Dental Health. EXTENDED IMAGING AND PHYSIOLOGICAL MEASUREMENTS Cardiac Ultrasound and Abdominal Aortic Measurements. Liver Elastography. Vascular Stiffness by cuff-based pulse wave analysis and Photoplethysmography (PPG). Valvular and Vascular Calcification by CT imaging.
Eligibility Criteria
Inclusion Criteria: Subjects already included in the main / general SCAPIS reexamination study in Stockholm. Exclusion Criteria: Inability to provide consent.
Frequently Asked Questions
Who can join the NCT07476703 clinical trial?
This trial is open to participants of all sexes, aged 56 Years or older, up to 74 Years, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07476703 currently recruiting?
Yes, NCT07476703 is actively recruiting participants. Visit ClinicalTrials.gov or contact Danderyd Hospital to inquire about joining.
Where is the NCT07476703 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07476703 clinical trial?
NCT07476703 is sponsored by Danderyd Hospital. The trial plans to enroll 1,400 participants.